Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Astellas
Pharma
Led by Lilly, 8 companies reach double-digit revenue gains in Q1
Sales trended upward in the first quarter of this year as eight of the biopharma industry’s top-25 companies had double-digit year-over-year growth.
Kevin Dunleavy
May 21, 2026 9:00am
Sun-Organon, Astellas, BeOne—Fierce Pharma Asia
May 1, 2026 8:43am
Astellas projects Xtandi decline but overall growth in FY2026
Apr 27, 2026 11:30am
Astellas, GSK-Hansoh, Daiichi—Fierce Pharma Asia
Apr 17, 2026 9:15am
Astellas manufacturing chief talks strategy 1 year into role
Apr 15, 2026 10:35am
Takeda-Denali, Merck-Zhifei, Shionogi—Fierce Pharma Asia
Apr 10, 2026 8:00am
